Sorry, you need to enable JavaScript to visit this website.

Safety and Efficacy of Dexmedetomidine (DEX) for Sedation in Children Aged Between 1 Month and Up to 17 Years Undergoing an MRI Scan

Safety and Efficacy of Dexmedetomidine (DEX) for Sedation in Children Aged Between 1 Month and Up to 17 Years Undergoing an MRI Scan. A Phase 3/4 Randomized, Double-Blind, Dose-Ranging Study of the Safety and Efficacy of Dexmedetomidine (DEX) Used With Propofol (PRO) as Needed for
Procedural Sedation of Pediatric Subjects ≥1 Month to <17 Years of age Undergoing MRI Scans.

Category & Conditions: Neurological Diseases and Conditions
Medicine: PRECEDEX™(DEXMEDETOMIDINE HYDROCHLORIDE)
ClinicalTrials.gov Identifier (NCT): NCT04237792
Protocol ID: C0801039
    Share
PrintDownload
Open Plain Language Summary Result: Click here